Novel immunopotent recombinant protein with simultaneous induction of cellular and humoral immune responses and broad spectrum of protective efficacy, and foot-and-mouth disease (FMD) vaccine composition comprising the same
KR102168646B1
Vaccine composition comprising PCV2d recombinant protein
KR102194347B1
Live Attenuated Porcine Epidemic Diarrhea Virus Vaccine Strain, Composition Containing Thereof, and Method of Producing Thereof
KR102208001B1
Composition for simultaneous detection of porcine circovirus type 2 and type 3 and use thereof
KR20190122634A
Primers for LAMP based detection of Reticuloendotheliosis virus in poultry and its use
KR20190122635A
Primers for LAMP based detection of Infectious bursal disease virus in poultry and its use
KR20190122633A
Primers for LAMP based detection of Marek's disease virus in poultry and its use
KR20210027720A
valuation method of efficacy of disinfection facility using gene quantification method
KR20210012695A
Suspension Cell Culture Adapted Vaccine Strain Derived from Foot-and-mouth disease virus of A/ASIA/Sea-97 Lineage and the Viral Vaccine Composition Containing the Same
KR20210012696A
Suspension Cell Culture Adapted Vaccine Strain Derived from Foot-and-mouth disease virus of O/ME-SA/Ind-2001 Lineage and the Viral Vaccine Composition Containing the Same
KR20210004221A
antibiotic composition comprising alpha-mangostin, gamma mangostin or celastrol
KR20210001522A
A composition for preventing and treating american foulbrood of bee, which is an antibiotic substitute derived from a natural plant extract
KR20200143140A
Composition for preserving blood applied to IFN-γ assay for diagnosing Bovine tuberculosis and uses thereof
KR102180778B1
Method for storing seed virus for preparing a foot-and-mouth disease vaccine, and a preservative for the same
KR20200134637A
Recombinant viruses expressing the foot-and-mouth disease type A protective antigen which inserted long term immunity enhancing gene, and a vaccine composition comprising the same
KR20200131560A
Novel Method for producing foot-and-mouth disease vaccine antigen
KR102117812B1
Recombinant Canine Parvovirus 2a VP2 and 2b VP2 Antigenic Protein and Use Thereof
KR20200122467A
Monoclonal Antibody specific for Canine Parvovirus and use thereof
KR20200122465A
Monoclonal Antibody specific for Porcine Parvovirus and use thereof
KR20200121425A
An antibody having immune reactivity to Foot-and-Mouth Disease Virus type O and composition for detecting FMDV type O comprising the same
